<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR145">
 <label>145.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zaman</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Dudman</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Stene-Johansen</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Qadri</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Yunus</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Sandbu</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Gurley</surname>
    <given-names>ES</given-names>
   </name>
   <name>
    <surname>Overbo</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Julin</surname>
    <given-names>CH</given-names>
   </name>
   <name>
    <surname>Dembinski</surname>
    <given-names>JL</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh</article-title>
  <source>BMJ Open</source>
  <year>2020</year>
  <volume>10</volume>
  <fpage>e033702</fpage>
  <?supplied-pmid 31959609?>
  <pub-id pub-id-type="pmid">31959609</pub-id>
 </element-citation>
</ref>
